Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

COVID-19

  • Article

    Comparison of Standard Dose, High Dose, and Therapeutic Anticoagulation in Hypoxemic COVID-19 Patients

    April 1, 2024

    Clinical question: Does standard-dose prophylactic anticoagulation (SD-PA), high-dose prophylactic anticoagulation (HD-PA), or therapeutic anticoagulation (TA) have a greater benefit in patients with...

  • Article

    Longer-term Outcomes in Critically Ill Patients with COVID-19 in the REMAP-CAP Trial

    March 1, 2024

    Clinical question: What is the longer-term (180-day) mortality effect of common therapies on critically ill patients with COVID-19? Background: Most randomized clinical trials for patients with...

  • Article

    Abatacept and Infliximab May Improve Mortality in Patients Hospitalized with COVID-19 Pneumonia

    February 1, 2024

    Dr. Rose Clinical question: What immunomodulatory drugs should we use in hospitalized patients with COVID-19 in addition to corticosteroids? Background: Inflammation is a key driver of morbidity...

  • Article

    Remdesivir Use Improves Mortality in COVID-19 in Non-ventilated Hospitalized Patients

    April 3, 2023

    Dr. Gibson Clinical question: Does remdesivir have a mortality benefit in patients with COVID-19? Background: The Solidarity trial previously reported preliminary mortality analyses for...

  • Article

    Update: Caring for COVID-19 Patients in the Hospital

    January 3, 2023

    Severe cases of COVID-19 infections continue to necessitate hospitalization more than two and a half years after the pandemic first hit. A total of 26,996 patients were hospitalized with COVID-19 in...

  • Article

    Low-dose Rivaroxaban at Discharge Prevented Some VTE Events at One Month for High-risk Patients Recovering from COVID-19

    September 1, 2022

    Dr. Thazhatuveetil-Kunhahamed Clinical Question: Is extended rivaroxaban prophylaxis (10 mg daily for 35 days) protective against arterial and venous thromboembolism (VTE) events in COVID-19...

  • Article

    COVID-19 Has Shown the Power of HM

    July 1, 2022

    Amid the unspeakable tragedies and hardships that the COVID-19 pandemic brought to the medical community are examples of stunning acts of innovation, compassion, and old-fashioned effort. Dr....

  • Article

    Hospitalists Recount the Struggles of Parenting During COVID-19

    July 1, 2022

    Mary Fredrickson, MD, a hospitalist at HealthPartners and assistant professor of medicine at the University of Minnesota, already had a hectic life before COVID-19, with four children ages 5 to 21,...

  • Article

    Steroid Dosing, Surgery Outcomes for COVID-19 Patients, and More: Highlights from 2021 Research

    July 1, 2022

    Drs. Frank and Grant did an outstanding job with their in-person In the Literature at SHM Converge. Whether to use a standard or a personalized dose of corticosteroids in hospitalized patients...

  • Article

    Statins should be continued in hospitalized patients with COVID-19

    May 2, 2022

    Clinical question: Does discontinuation of atorvastatin in those hospitalized with COVID-19 change the risk of mortality and ventilation? Dr. Clark Background: Statins are ubiquitous. Statins...

1 2 3 … 133Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences